Association between pediatric psoriasis and the metabolic syndrome - 13/05/12
Doi : 10.1016/j.jaad.2011.11.935
Shiu-chung Au, MD a, ⁎ 
, Ari M. Goldminz, BA c, Daniel S. Loo, MD a, Nicole Dumont a, Danielle Levine, MD a, Eva Volf, MD a, Melissa Michelon, MD a, Andrew Wang, MD a, Noori Kim, MD a, Shimrat Yaniv, BA a, Paul F. Lizzul, MD, PhD, MBA, MPH a, Todd Kerensky, MD a, Jorge M. Lopez-Benitez, MD b, Marc Natter, MD b, Laurie Miller, MD b, Christina F. Pelajo, MD, MSc b, Trevor Davis, MD b, Alice B. Gottlieb, MD, PhD a
, Ari M. Goldminz, BA c, Daniel S. Loo, MD a, Nicole Dumont a, Danielle Levine, MD a, Eva Volf, MD a, Melissa Michelon, MD a, Andrew Wang, MD a, Noori Kim, MD a, Shimrat Yaniv, BA a, Paul F. Lizzul, MD, PhD, MBA, MPH a, Todd Kerensky, MD a, Jorge M. Lopez-Benitez, MD b, Marc Natter, MD b, Laurie Miller, MD b, Christina F. Pelajo, MD, MSc b, Trevor Davis, MD b, Alice B. Gottlieb, MD, PhD a a Department of Dermatology, Tufts Medical Center, Boston, Massachusetts
b Department of Pediatric Rheumatology, Tufts Medical Center, Boston, Massachusetts
c Tufts University School of Medicine, Boston, Massachusetts
Correspondence to: Shiu-chung Au, MD, Tufts Medical Center, 800 Washington St, Box 114, Boston, MA 02111| This investigator-initiated project was funded by a grant from Amgen Inc. |
|
| Disclosure: Dr Gottlieb currently has consulting/advisory board agreements with the following: Abbott Laboratories, Actelion, Alnylam, Amgen, Beiersdorf Inc, Astellas Pharma US Inc, BIND Biosciences Inc, Canfite, Celgene Corp, Centocor Ortho Biotech Inc, Cytokine Pharmasciences, DermiPsor, Incyte Corp, Merck & Co Inc, Novo Nordisk A/S, Ono, Pfizer Inc, Pharmaceutical Product Development Inc, Puretech, Schering-Plough Corp, and UCB. Dr Gottlieb is the principal investigator for research/educational grants awarded to Tufts Medical Center from Abbott Laboratories, Amgen, Celgene, Centocor Ortho Biotech Inc, Immune Control, Novo Nordisk A/S, Pfizer Inc, and UCB. Dr Lizzul is an investigator with the following: Abbott Laboratories, Centocor Ortho Biotech Inc, Celgene Corp, Pfizer Inc, and Novartis Inc. The remaining authors have no conflicts of interest to declare. |
© 2011
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 66 - N° 6
P. 1012-1013 - juin 2012 Retour au numéro
Article précédent
- Refusal of shingles vaccine: Implications for public health
- Angela L. Funovits, Kyle L. Wagamon, Eliot N. Mostow, Robert T. Brodell
- Lipodermatosclerosis: Improvement noted with hydroxychloroquine and pentoxifylline
- Charoen Choonhakarn, Suteeraporn Chaowattanapanit
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?